bioAffinity Technologies (BIAF) Return on Assets (2022 - 2026)

bioAffinity Technologies (BIAF) has reported Return on Assets for 5 consecutive years, with 0.02% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
• Return on Assets retreated to 0.02% in Q1 2026 per BIAF's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.01% in Q4 2022 and bottomed at 0.02% in Q2 2025.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
• Annual changes were most pronounced in 2023 — Return on Assets changed 0 bps — and 2024, when it decreased 1 bps.
• bioAffinity Technologies' Return on Assets stood at 0.01% in 2022, then tumbled by 39 bps to 0.01% in 2023, then sank by 60 bps to 0.01% in 2024, then increased by 4 bps to 0.01% in 2025, then declined by 27 bps to 0.02% in 2026.
• Business Quant data shows BIAF's Return on Assets at 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.